NovoCure Ltd
(BSP:N2VC34)
R$
7.98
(0%)
Market Cap: 929.27 Mil
Enterprise Value: -123.68 Mil
PE Ratio: 0
PB Ratio: 5.64
GF Score: 48/100 Novocure Ltd LUNAR Phase 3 Clinical Trial Presentation Transcript
Jun 06, 2023 / 07:00PM GMT
William F. Doyle
NovoCure Limited - Executive Chairman
Hello, everyone. For those of you who don't know me, I'm Bill Doyle. I'm the Executive Chairman
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot